Want to see JP:4934 full AI Analyst Report?
4934 Stock Chart & Stats
¥702.00
-¥12.00(-1.43%)
At close: 4:00 PM EST
¥702.00
-¥12.00(-1.43%)
Day’s Range― - ―
52-Week Range¥576.00 - ¥950.00
Previous CloseN/A
Volume17.40K
Average Volume (3M)11.01K
Market Cap
¥5.33B
Enterprise Value¥1.61B
Total Cash (Recent Filing)¥4.66B
Total Debt (Recent Filing)¥1.11B
Price to Earnings (P/E)21.2
Beta0.91
Next Earnings
Sep 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)54.02
Shares Outstanding8,720,534
10 Day Avg. Volume8,960
30 Day Avg. Volume11,006
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.14
Price to Sales (P/S)0.47
P/FCF Ratio5.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)37.8
Revenue Forecast (FY)¥14.40B
Bulls Say, Bears Say
Bulls Say
High Gross Profit MarginA 76.65% gross margin indicates durable product pricing power or low direct costs in the anti‑aging consumer services model. This margin cushion supports long‑term profitability resilience even if top‑line growth is uneven, enabling reinvestment or margin recovery efforts.
Conservative Balance Sheet / Low LeverageA debt-to-equity of 0.17 and healthy equity ratio reflect conservative capital structure and financial flexibility. Low leverage reduces refinancing and solvency risk, allowing the company to fund operations or strategic initiatives without excessive interest burden across economic cycles.
Strong Free Cash Flow ConversionA near‑1.0 free cash flow to net income ratio shows effective conversion of accounting profits into cash. This durable cash generation ability supports funding of working capital, capex or deleveraging, and reduces dependence on external financing for core operations.
Bears Say
Declining Revenue TrendSustained revenue declines constrain operational scale and make fixed costs a larger share of the business, pressuring margins and limiting reinvestment. If top‑line erosion persists, it undermines long‑term profitability improvement and market positioning in the sector.
Low Net And Operating MarginsVery low net and operating margins indicate weak cost absorption beyond gross profit, limiting retained earnings and reinvestment. Over time, persistently thin margins reduce strategic optionality, make returns sensitive to cost inflation, and hinder competitive reinvestment.
Material EPS ContractionA steep EPS decline signals earnings pressure and reduced shareholder returns, reflecting margin or volume weakness. Such contraction can limit managerial flexibility, weaken investor confidence, and constrain the company's ability to fund strategic initiatives without external capital.
Premier Anti-Aging Co., Ltd. News
4934 FAQ
What was Premier Anti-Aging Co., Ltd.’s price range in the past 12 months?
Premier Anti-Aging Co., Ltd. lowest stock price was ¥576.00 and its highest was ¥950.00 in the past 12 months.
What is Premier Anti-Aging Co., Ltd.’s market cap?
Premier Anti-Aging Co., Ltd.’s market cap is ¥5.33B.
When is Premier Anti-Aging Co., Ltd.’s upcoming earnings report date?
Premier Anti-Aging Co., Ltd.’s upcoming earnings report date is Sep 10, 2026 which is in 71 days.
How were Premier Anti-Aging Co., Ltd.’s earnings last quarter?
Premier Anti-Aging Co., Ltd. released its earnings results on Jun 12, 2026. The company reported ¥11.14 earnings per share for the quarter, beating the consensus estimate of N/A by ¥11.14.
Is Premier Anti-Aging Co., Ltd. overvalued?
According to Wall Street analysts Premier Anti-Aging Co., Ltd.’s price is currently Overvalued.
Does Premier Anti-Aging Co., Ltd. pay dividends?
Premier Anti-Aging Co., Ltd. does not currently pay dividends.
What is Premier Anti-Aging Co., Ltd.’s EPS estimate?
Premier Anti-Aging Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Premier Anti-Aging Co., Ltd. have?
Premier Anti-Aging Co., Ltd. has 8,720,534 shares outstanding.
What happened to Premier Anti-Aging Co., Ltd.’s price movement after its last earnings report?
Premier Anti-Aging Co., Ltd. reported an EPS of ¥11.14 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.332%.
Which hedge fund is a major shareholder of Premier Anti-Aging Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4934
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Premier Anti-Aging Co., Ltd.
Premier Anti-Aging Co., Ltd. engages in the planning, development, import, export, mail order/EC, wholesale, and retail of cosmetics, health foods, and recovery wear in Japan. The company is involved in anti-aging and recovery businesses; and manufactures and sells skin care, hair care, and inner care products. It offers its products under the DUO, CANADEL, Clayence, C+mania, Sinto, Sitrana, Reinca, and Lalaskin brands. The company was incorporated in 2009 and is headquartered in Minato, Japan.
Technical Analysis
Ivy Cosmetics Corporation
―
HABA Laboratories, Inc.
―
C'BON COSMETICS Co., Ltd.
―
I-ne CO., LTD.
―
AXXZIA, Inc.
―